Stocks Down Under Videos
Get a 3-month FREE TRIAL to CONCIERGE now!
Concierge gives you timely BUY and SELL alerts on ASX-listed stocks
DorsaVi (ASX:DVL) unveiled its ambitious 22nm ReRAM strategy: Interview with Group CEO Mathew Regan
January 28, 2026
DVL, Dorsavi, ReRAM
DorsaVi (ASX:DVL) is switching into high gear
We spoke to DorsaVi’s Group CEO, Mat Regan, about the company’s new research collaboration with ITRI in Taiwan, and how this fits into DVL’s 22 nanometer ReRAM development strategy.
DorsaVi already has a R&D collaboration in place with NTU in Singapore and has recently acquired an extensive neuromorphic processing IP portfolio.
We also spoke about end applications for the technology once commercially available. These include Robotics and Medical applications as well as Autonomous Vehicles, like drones and cars.
Lastly, we discussed one of DVL’s target markets for neuromorphic computing, which is expected to grow very fast in the next 5 to US$20bn in 2030.
Check out the latest research on DVL by Pitt Street Research!
Looking for the Best ASX semiconductor stocks to invest in right now?
